Loading…

Expression of LINE-1 retroposons is essential for murine preimplantation development

In higher eukaryotes, reverse transcriptase (RT) activities are encoded by a variety of endogenous retroviruses and retrotransposable elements. We previously found that mouse preimplantation embryos are endowed with an endogenous RT activity. Inhibition of that activity by the non nucleosidic inhibi...

Full description

Saved in:
Bibliographic Details
Published in:Molecular reproduction and development 2006-03, Vol.73 (3), p.279-287
Main Authors: Beraldi, Rosanna, Pittoggi, Carmine, Sciamanna, Ilaria, Mattei, Elisabetta, Spadafora, Corrado
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:In higher eukaryotes, reverse transcriptase (RT) activities are encoded by a variety of endogenous retroviruses and retrotransposable elements. We previously found that mouse preimplantation embryos are endowed with an endogenous RT activity. Inhibition of that activity by the non nucleosidic inhibitor nevirapine or by microinjection of anti‐RT antibody caused early embryonic developmental arrest. Those experiments indicated that RT is required for early development, but did not identify the responsible coding elements. We now show that microinjection of morpholino‐modified antisense oligonucleotides targeting the 5′ end region of active LINE‐1 retrotransposons in murine zygotes irreversibly arrests preimplantation development at the two‐ and four‐cell stages; the overall level of functional RT is concomitantly downregulated in arrested embryos. Furthermore, we show that the induction of embryo developmental arrest is associated with a substantial reprogramming of gene expression. Together, these results support the conclusion that expression of LINE‐1 retrotransposons is required for early embryo preimplantation development. Mol. Reprod. Dev. © 2005 Wiley‐Liss, Inc.
ISSN:1040-452X
1098-2795
DOI:10.1002/mrd.20423